Dexcom reported strong financial results for the first quarter of 2026, with revenue increasing 15% year-over-year to $1.192 billion. The company expa...
Bullish
DexCom's upcoming 15-day G7 continuous glucose monitoring (CGM) sensor is generating optimism ahead of its recent earnings release, reinforcing the co...
Bullish
DexCom Inc (DXCM) shares recently fell by 3.1% to $62.60, currently trading significantly below its GF Value™ of $109.23, which suggests the stock is ...
Bullish
Dexcom Inc. is a leader in continuous glucose monitoring (CGM) systems, with products like the Dexcom G7 transforming diabetes management. The company...
Neutral
Michael Jon Brown, Dexcom Inc.'s EVP and Chief Legal Officer, sold 1,700 shares of common stock at $63.04 each through a pre-arranged Rule 10b5-1 trad...
Neutral
DEXCOM INC's President & CEO, Jacob Leach, is estimated to have received $7,985,960 in compensation in 2025, a 25.84% increase from 2024, based on a n...
Bullish
Dexcom Inc. is a leader in continuous glucose monitoring (CGM) systems, with its technology addressing the needs of over 38 million Americans with dia...
Neutral
Dexcom Inc. is a leader in continuous glucose monitoring (CGM) technology, providing real-time blood sugar data for diabetes patients, positioning it ...